Sanofi launches Enterogermina, a new treatment for gastrointestinal disorders
- United Arab Emirates: Sunday, January 27 - 2013 at 16:06
- PRESS RELEASE
Sanofi, a global diversified healthcare leader, has launched Enterogermina, a probiotic also known as bacillus clausii that is used to restore the intestinal bacterial balance in case of an intestinal disorder.
"Although we are born with these microorganisms in our bodies, poor dietary habits can disrupt the levels of microbiota in the system and cause more damage than harm," said Dr, Antonio Gasbarrini, M.D from the Internal Medicine Department at Catholic University, Gemelli Hospital, Italy, who presented on the importance of using probiotics in the efforts to maintain a healthy number of bacteria. "Probiotics and postbiotics are part of biotherapy, a new direction in medicine when treating infections and gastric conditions."
Conditions like diabetes, obesity or an inappropriate use of medications such as antibiotics can be linked to adiposity, which occurs when person weight is no longer controlled by these microbes. It is when probiotics can be prescribes to return the balance within the gastrointestinal tract.
"Bacillus clausii is part of a new class of probiotics that help stimulates the immune system to protect the gastrointestinal tract against infection or other gastrointestinal diseases," said Dr. Mohamad Miqdady, M.D., Head of Pediatric Gastroenterology at Sheikh Khalifa Medical City in Abu Dhabi, "Due to the increasing number of diabetes and obesity cases in the UAE, gastrointestinal diseases cases are also on the rise. Probiotics such as Enterogermina, are prescribed as part of the treatment to manage the microbiota in the system."
Enterogermina is now available in the UAE at pharmacies. Speak to a doctor before taking any medications.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.